IMAC (IMAC) Competitors $0.07 +0.00 (+1.39%) As of 10/9/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFDA EventsHeadlinesSEC FilingsTrendsBuy This Stock IMAC vs. OBSV, SSKN, TTNP, PPBT, CDIO, BCLI, AMIX, EVOK, SNOA, and AQBShould you be buying IMAC stock or one of its competitors? The main competitors of IMAC include ObsEva (OBSV), Strata Skin Sciences (SSKN), Titan Pharmaceuticals (TTNP), Purple Biotech (PPBT), Cardio Diagnostics (CDIO), Brainstorm Cell Therapeutics (BCLI), Autonomix Medical (AMIX), Evoke Pharma (EVOK), Sonoma Pharmaceuticals (SNOA), and AquaBounty Technologies (AQB). These companies are all part of the "medical" sector. IMAC vs. Its Competitors ObsEva Strata Skin Sciences Titan Pharmaceuticals Purple Biotech Cardio Diagnostics Brainstorm Cell Therapeutics Autonomix Medical Evoke Pharma Sonoma Pharmaceuticals AquaBounty Technologies IMAC (NASDAQ:IMAC) and ObsEva (NASDAQ:OBSV) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk. Is IMAC or OBSV more profitable? ObsEva has a net margin of 0.00% compared to IMAC's net margin of -75.40%. IMAC's return on equity of -52.17% beat ObsEva's return on equity.Company Net Margins Return on Equity Return on Assets IMAC-75.40% -52.17% -34.51% ObsEva N/A -416.36%-92.01% Do insiders and institutionals hold more shares of IMAC or OBSV? 24.3% of IMAC shares are owned by institutional investors. Comparatively, 17.5% of ObsEva shares are owned by institutional investors. 10.0% of IMAC shares are owned by company insiders. Comparatively, 14.4% of ObsEva shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media favor IMAC or OBSV? In the previous week, IMAC had 2 more articles in the media than ObsEva. MarketBeat recorded 2 mentions for IMAC and 0 mentions for ObsEva. ObsEva's average media sentiment score of 0.00 beat IMAC's score of -0.75 indicating that ObsEva is being referred to more favorably in the news media. Company Overall Sentiment IMAC Negative ObsEva Neutral Which has more volatility & risk, IMAC or OBSV? IMAC has a beta of -0.88, suggesting that its share price is 188% less volatile than the S&P 500. Comparatively, ObsEva has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Which has stronger valuation & earnings, IMAC or OBSV? IMAC has higher revenue and earnings than ObsEva. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIMAC$15.22M0.13-$10.54MN/AN/AObsEvaN/AN/A-$58.38M-$0.92N/A SummaryIMAC beats ObsEva on 6 of the 10 factors compared between the two stocks. Get IMAC News Delivered to You Automatically Sign up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IMAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IMAC vs. The Competition Export to ExcelMetricIMACSpecialty Outpatient Clinics IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.93M$1.37M$6.12B$10.64BDividend YieldN/AN/A5.66%4.69%P/E RatioN/AN/A86.1127.75Price / Sales0.130.13588.17183.92Price / CashN/AN/A38.3262.20Price / Book0.110.1112.976.80Net Income-$10.54M-$10.54M$3.30B$275.97M7 Day PerformanceN/AN/A3.27%2.08%1 Month PerformanceN/AN/A10.12%9.09%1 Year PerformanceN/AN/A83.41%36.72% IMAC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IMACIMACN/A$0.07+1.4%N/A-93.2%$1.93M$15.22M0.00106OBSVObsEvaN/AN/AN/AN/A$7.94MN/A0.0050SSKNStrata Skin Sciences2.2721 of 5 stars$1.93+1.6%$6.00+210.9%-35.0%$7.93M$33.56M-0.68120Analyst ForecastTTNPTitan Pharmaceuticals0.8366 of 5 stars$5.93+23.7%N/A+18.5%$7.88MN/A-2.0110Positive NewsHigh Trading VolumePPBTPurple Biotech1.8636 of 5 stars$0.58-4.7%$33.00+5,581.8%-85.2%$7.83MN/A-1.3820Negative NewsAnalyst ForecastGap DownCDIOCardio Diagnostics0.6367 of 5 stars$4.37-0.5%N/A-27.6%$7.75M$40K0.001Analyst ForecastGap UpBCLIBrainstorm Cell Therapeutics1.156 of 5 stars$0.70+1.4%N/A-65.0%$7.72MN/A-0.2140AMIXAutonomix Medical2.7737 of 5 stars$1.15-3.8%$5.00+336.7%-89.5%$7.37MN/A-0.201News CoverageAnalyst ForecastEVOKEvoke Pharma0.7819 of 5 stars$4.71+0.6%N/A-6.2%$7.29M$10.25M-1.844News CoverageAnalyst ForecastHigh Trading VolumeSNOASonoma Pharmaceuticals0.5424 of 5 stars$4.25-3.4%N/A+53.1%$7.23M$14.29M-1.73180News CoverageAnalyst ForecastHigh Trading VolumeAQBAquaBounty Technologies1.3149 of 5 stars$2.10+12.9%N/A+73.9%$7.21M$2.47M-0.11100Positive NewsAnalyst Forecast Related Companies and Tools Related Companies ObsEva Competitors Strata Skin Sciences Competitors Titan Pharmaceuticals Competitors Purple Biotech Competitors Cardio Diagnostics Competitors Brainstorm Cell Therapeutics Competitors Autonomix Medical Competitors Evoke Pharma Competitors Sonoma Pharmaceuticals Competitors AquaBounty Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IMAC) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredTrump to get REVENGE on the banks??Rumors are swirling that Trump could target the banking system by upending the $5 trillion-a-day SWIFT network...The Oxford Club | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.For the everyday American who's worked hard to build their nest egg, Trump preserved a IRS loophole that allow...American Hartford Gold | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMAC Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMAC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
